Pfizer RSV vaccine for infants has 'generally favorable' safety data, FDA staff sayThe FDA is slated to make a decision on whether to approve Pfizer's shot in August before respiratory syncytial virus season in the fall.[Collection]

The FDA is slated to make a decision on whether to approve Pfizer's shot in August before respiratory syncytial virus season in the fall.https://www.cnbc.com/2023/05/16/pfizer-rsv-shot-for-infants-has-favorable-safety-data-fda-staff-say.html